Comparison of short-term surgical outcomes between men and women with breast cancer: a retrospective study using nationwide inpatient data in Japan
- PMID: 33398479
- DOI: 10.1007/s10549-020-06069-4
Comparison of short-term surgical outcomes between men and women with breast cancer: a retrospective study using nationwide inpatient data in Japan
Abstract
Purpose: Although long-term survival is similar between men and women, little is known about the short-term outcomes following breast cancer surgery in men. This study was performed to compare postoperative outcomes adjusted for background factors between men and women with breast cancer using a Japanese nationwide inpatient database.
Methods: This study included 2126 men and 363,468 women who underwent surgery for stage 0-III breast cancer from July 2010 to March 2017. We generated a 1:4 matched-pair cohort matched for age, institution, and fiscal year at admission. We then conducted multivariable regression analyses to compare postoperative complications, 30-day readmission, duration of anesthesia, length of hospitalization, and total hospitalization costs between the sexes.
Results: Men were older, more likely to have comorbidities and advanced cancer, and more likely to undergo total mastectomy and axillary dissection than women. There were no significant differences in postoperative complications between the sexes, but men showed a lower risk of 30-day readmission (odds ratio 0.74; 95% confidence interval [CI] 0.57-0.95), shorter duration of anesthesia (difference - 22.0 min; 95% CI - 2.1 to - 0.5), shorter length of hospitalization (difference - 1.3 days; 95% CI - 2.1 to - 0.5), and lower total hospitalization costs (difference - 506 US dollars; 95% CI - 668 to - 334) than women.
Conclusions: The matched-pair cohort analyses revealed no significant differences in postoperative complications between men and women with breast cancer. However, men showed better outcomes than women in terms of 30-day readmission, duration of anesthesia, length of hospitalization, and total hospitalization costs.
Keywords: Male breast cancer; Mastectomy; Postoperative outcomes; Sex differences.
Similar articles
-
Comparisons of postoperative outcomes after breast cancer surgery in patients with and without renal replacement therapy: a matched-pair cohort study using a Japanese nationwide inpatient database.Breast Cancer. 2021 Sep;28(5):1112-1119. doi: 10.1007/s12282-021-01248-7. Epub 2021 Apr 10. Breast Cancer. 2021. PMID: 33837897
-
Impact of Body Mass Index on Outcomes After Breast Cancer Surgery: Nationwide Inpatient Database Study in Japan.Clin Breast Cancer. 2020 Dec;20(6):e663-e674. doi: 10.1016/j.clbc.2020.05.002. Epub 2020 May 11. Clin Breast Cancer. 2020. PMID: 32800491
-
Short-Term Outcomes Following Breast Cancer Surgery With and Without Neoadjuvant Chemotherapy: A Nationwide Administrative Database Study in Japan.Ann Surg Oncol. 2022 May;29(5):3000-3010. doi: 10.1245/s10434-021-11212-6. Epub 2022 Jan 7. Ann Surg Oncol. 2022. PMID: 34994909
-
Surgical and obstetric outcomes of breast cancer surgery during pregnancy: a nationwide database study in Japan.Breast Cancer Res Treat. 2022 Oct;195(3):289-299. doi: 10.1007/s10549-022-06659-4. Epub 2022 Aug 2. Breast Cancer Res Treat. 2022. PMID: 35917051
-
Association between body mass index and outcomes after autologous breast reconstruction: a nationwide inpatient database study in Japan.Breast Cancer Res Treat. 2024 Feb;204(1):69-78. doi: 10.1007/s10549-023-07162-0. Epub 2023 Nov 15. Breast Cancer Res Treat. 2024. PMID: 37966699
Cited by
-
Association between body mass index and incidence of breast cancer in premenopausal women: a Japanese nationwide database study.Breast Cancer Res Treat. 2022 Jul;194(2):315-325. doi: 10.1007/s10549-022-06638-9. Epub 2022 Jun 4. Breast Cancer Res Treat. 2022. PMID: 35665439
-
Unveiling the comorbidity burden of male breast cancer.Sci Rep. 2024 Oct 3;14(1):22977. doi: 10.1038/s41598-024-73032-4. Sci Rep. 2024. PMID: 39362912 Free PMC article.
-
Clinical Information and Prognosis of High-risk Luminal Breast Cancer Subjects Eligible for the MonarhE Study.JMA J. 2025 Apr 28;8(2):486-497. doi: 10.31662/jmaj.2024-0243. Epub 2025 Feb 14. JMA J. 2025. PMID: 40416017 Free PMC article.
-
Evaluation of Complications of Short-term and Long-term Drainage Following Mastectomy with Removal of Axillary Lymph Nodes: A Randomized Clinical Trial.Asian Pac J Cancer Prev. 2022 Aug 1;23(8):2873-2878. doi: 10.31557/APJCP.2022.23.8.2873. Asian Pac J Cancer Prev. 2022. PMID: 36037146 Free PMC article. Clinical Trial.
-
Risk Factors for Postoperative Bleeding Following Breast Cancer Surgery: A Nationwide Database Study of 477,108 Cases in Japan.World J Surg. 2022 Dec;46(12):3062-3071. doi: 10.1007/s00268-022-06746-z. Epub 2022 Sep 25. World J Surg. 2022. PMID: 36155832
References
-
- Korde LA, Zujewski JA, Kamin L et al (2010) Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 28:2114–2122. https://doi.org/10.1200/JCO.2009.25.5729 - DOI - PubMed - PMC
-
- Hong JH, Ha KS, Jung YH et al (2016) Clinical features of male breast cancer: experiences from seven institutions over 20 years. Cancer Res Treat 48:1389–1398. https://doi.org/10.4143/crt.2015.410 - DOI - PubMed - PMC
-
- Cardoso F, Bartlett JMS, Slaets L et al (2018) Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Ann Oncol 29:405–417. https://doi.org/10.1093/annonc/mdx651 - DOI - PubMed
-
- Yadav S, Karam D, Bin Riaz I et al (2020) Male breast cancer in the United States: treatment patterns and prognostic factors in the 21st century. Cancer 126:26–36. https://doi.org/10.1002/cncr.32472 - DOI - PubMed
-
- Anderson WF, Althuis MD, Brinton LA, Devesa SS (2004) Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83:77–86. https://doi.org/10.1023/B:BREA.0000010701.08825.2d - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical